Think drugs are expensive in the U.S.? Just try China

19 March 2019 - Beijing will want pharma companies to share the pain of the country’s growing health care costs. ...

Read more →

China moves to expand cancer medicine access

6 March 2019 - China's recent policy to increase patients' access to cancer medicines has helped more people receive quality ...

Read more →

China approves first biosimilar of foreign drug, breaking Roche monopoly

27 February 2019 - China’s National Medical Products Administration announced Monday that it has approved the country's first biosimilar drug ...

Read more →

China to establish collaboration network for rare disease diagnosis, treatment

18 February 2019 - China will establish a national collaborative network of hospitals for rare disease diagnosis and treatment to ...

Read more →

China pushes forward reforms to expand access to anti-cancer drugs

13 February 2019 - Life-saving anti-cancer drugs, once hard to afford or find on the market by many patients in ...

Read more →

Pfizer launches China's first pay for performance model for cancer

26 January 2019 - Pfizer launched a pay-for-performance insurance program for its breast cancer drug Ibrance palbociclib in China. The ...

Read more →

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

19 January 2019 - New policy environment demanding cheaper drugs adds pressure to innovate. ...

Read more →

China unveils pilot "group-buying" plan to cut drug prices

17 January 2019 - China has unveiled a pilot medicine procurement program to be tried in 11 major cities to ...

Read more →

China has a very unhealthy interest in our medical data

14 January 2019 - Chinese companies are required by law to obey directives from Beijing's intelligence agencies. So why would ...

Read more →

Pharma firms face shake-up with China’s plan to bulk-buy drugs

2 January 2019 - Pilot programme involves major cities clubbing together to purchase certain medicines, driving down prices. ...

Read more →

Roxadustat approved in China for the treatment of anaemia in chronic kidney disease patients on dialysis

18 December 2018 - China is the first country to approve roxadustat. ...

Read more →

‘Painful’ consolidation ahead for China’s generic drug makers, as Beijing gets behind procurement revamp

17 December 2018 - 52% difference in price on average between winning bids under centralised bulk drugs procurement pilot and last ...

Read more →

China drug prices were cut more than expected, Credit Suisse says

10 December 2018 - Serena Shao, head of China healthcare research at Credit Suisse, talks about Chin's health care stocks.  ...

Read more →

Chinese vice premier calls for centralised medicine procurement to cut prices

7 December 2018 - Chinese Vice Premier Sun Chunlan on Friday stressed the need for centralized medicine procurement and market-oriented ...

Read more →

China's drug makers plunge most since 2009 on price concerns

6 December 2018 - Price of one drug was cut by 90% in official tender: report. ...

Read more →